EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C26H29ClN2O7 |
| Net Charge | 0 |
| Average Mass | 516.978 |
| Monoisotopic Mass | 516.16633 |
| SMILES | CC1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCCCCC(=O)O)c(O)c2C(=O)O1 |
| InChI | InChI=1S/C26H29ClN2O7/c1-15-12-17-19(27)14-18(23(32)22(17)26(35)36-15)24(33)29-20(13-16-8-4-2-5-9-16)25(34)28-11-7-3-6-10-21(30)31/h2,4-5,8-9,14-15,20,32H,3,6-7,10-13H2,1H3,(H,28,34)(H,29,33)(H,30,31)/t15?,20-/m0/s1 |
| InChIKey | CEPUVBUZIGYDKM-MBABXSBOSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Role: | hapten Any substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| hapten OTAe (CHEBI:141327) has functional parent ochratoxin A (CHEBI:7719) |
| hapten OTAe (CHEBI:141327) has role hapten (CHEBI:59174) |
| hapten OTAe (CHEBI:141327) is a N-acyl-L-phenylalanine (CHEBI:77673) |
| hapten OTAe (CHEBI:141327) is a diastereoisomeric mixture (CHEBI:60915) |
| hapten OTAe (CHEBI:141327) is a isochromanes (CHEBI:38762) |
| hapten OTAe (CHEBI:141327) is a monocarboxylic acid amide (CHEBI:29347) |
| hapten OTAe (CHEBI:141327) is a organochlorine compound (CHEBI:36683) |
| hapten OTAe (CHEBI:141327) is a phenylalanine derivative (CHEBI:25985) |
| IUPAC Name |
|---|
| 6-({(2S)-2-[(5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carbonyl)amino]-3-phenylpropanoyl}amino)hexanoic acid |
| Synonyms | Source |
|---|---|
| 6-{[(2S)-2-{[(5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-isochromen-7-yl)carbonyl]amino}-3-phenylpropanoyl]amino}hexanoic acid | IUPAC |
| 6-[[(2S)-2-[[(5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl]amino]-1-oxo-3-phenylpropyl]amino]hexanoic acid | ChEBI |
| Citations |
|---|